Mangalam Drugs & Organics

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue91.4087.4881.5997.34102.29
Expenses97.0497.7786.3397.2998.34
EBITDA0.54-3.452.226.9711.75
EBIT-2.22-6.88-1.513.357.89
Profit Before Tax-5.65-10.29-4.750.043.94
Net Profit-4.39-9.54-3.560.503.55
Financial Ratios
Operating Profit Margin0.59%-3.97%2.73%7.19%11.53%
Net Profit Margin-4.86%-10.97%-4.38%0.52%3.48%
Earning Per Share (Diluted)-2.77-6.02-2.250.322.24
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ